Mirko Theis

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Cell Cycle Arrest

Transcription Factor

Endoplasmic Reticulum Stress

Top Venues

Life science alliance

This page only lists publications with an associated author ORCID identifier.

Publications

Marietta Döring, Melanie Brux, Maciej Paszkowski-Rogacz, Pedro Manuel Guillem-Gloria, Frank Buchholz, M Teresa Pisabarro, Mirko Theis
Nucleolar protein TAAP1/ C22orf46 confers pro-survival signaling in non-small cell lung cancer. Life science alliance 7 (4) (2024)
Marietta Döring, Melanie Brux, Maciej Paszkowski-Rogacz, Pedro Manuel Guillem-Gloria, Frank Buchholz, M Teresa Pisabarro, Mirko Theis
Nucleolar protein TAAP1/ C22orf46 confers pro-survival signaling in non-small cell lung cancer. Life science alliance 7 (4) (2024)
Marietta Döring, Melanie Brux, Maciej Paszkowski-Rogacz, Pedro Manuel Guillem-Gloria, Frank Buchholz, M Teresa Pisabarro, Mirko Theis
Nucleolar protein TAAP1/ C22orf46 confers pro-survival signaling in non-small cell lung cancer. Life science alliance 7 (4) (2024)
Daniel Martin Klotz, Franziska Maria Schwarz, Anna Dubrovska, Kati Schuster, Mirko Theis, Alexander Krüger, Oliver Kutz, Theresa Link, Pauline Wimberger, Stephan Drukewitz, Frank Buchholz, Jürgen Thomale, Jan Dominik Kuhlmann
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer. Cancers 15 (15) (2023)
Sandeep Sreevalsan, Marietta Döring, Maciej Paszkowski-Rogacz, Melanie Brux, Carolina Blanck, Marten Meyer, Frank Momburg, Frank Buchholz, Mirko Theis
MLLT6 maintains PD-L1 expression and mediates tumor immune resistance. EMBO reports 21 (12) (2020)